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Directing stem cell fate requires knowledge of how signaling networks integrate temporally and spatially segregated
stimuli. We developed and validated a computational model of signal transducer and activator of transcription-3
(Stat3) pathway kinetics, a signaling network involved in embryonic stem cell (ESC) self-renewal. Our analysis
identified novel pathway responses; for example, overexpression of the receptor glycoprotein-130 results in reduced
pathway activation and increased ESC differentiation. We used a systematic in silico screen to identify novel targets
and protein interactions involved in Stat3 activation. Our analysis demonstrates that signaling activation and
desensitization (the inability to respond to ligand restimulation) is regulated by balancing the activation state of a
distributed set of parameters including nuclear export of Stat3, nuclear phosphatase activity, inhibition by suppressor
of cytokine signaling, and receptor trafficking. This knowledge was used to devise a temporally modulated ligand
delivery strategy that maximizes signaling activation and leads to enhanced ESC self-renewal.
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Introduction
Self-renewal is one of the deﬁning characteristics of
embryonic stem cells (ESCs) [1]. This fate choice is inﬂuenced
by ligand–receptor-mediated activation of intracellular sig-
naling pathways. Signiﬁcant work is being done to under-
stand the signaling proteins and pathways that control self-
renewal of ESCs, and an emerging picture is that these
pathways inﬂuence self-renewal in a context-dependent and
temporally modulated manner [2–4]. One such pathway is the
Jak/Stat3 (Janus kinase / signal transducer and activator of
transcription-3) pathway [5]. Activation of Stat3 by phos-
phorylation at Tyr-705 results in induction of genetic
programs that are sufﬁcient for maintenance of self-renewal
in mouse ESCs [6–8]. Understanding how Stat3 activation is
controlled may be useful for controlling ESC self-renewal.
Stat3 is activated by a variety of ligands from the
interlukin-6 (IL-6)–type family [9]. In mouse ESCs, Stat3
activation results from binding of leukemia inhibitor factor
(LIF) to the LIF receptor and glycoprotein-130 (GP130),
forming a heterodimeric receptor complex [10,11]. Jak-
mediated Src homology-2 (SH2)–domain phosphorylation of
receptors leads to Stat3 recruitment to the receptor complex
[12], and its Tyr-705 phosphorylation and subsequent nuclear
accumulation [13–25]. This pathway is under control of three
main inhibitors, protein inhibitor of activated Stat3 (PIAS3),
Src-2 homology containing phosphotyrosine phosphatase
(SHP2), and suppressor of cytokine signaling (SOCS3). PIAS3
and SHP2 work to reduce Stat3 availability [26] and receptor
activation [21,24–26], respectively, and SOCS3, which is under
transcription control of Stat3, inactivates activated receptors
by binding to GP130 [26,27]. Activation of Stat3 is therefore
inﬂuenced by a variety of intrinsic pathway components as
well as receptor trafﬁcking [28,29]. Understanding how this
signaling is controlled presents a challenge which may be best
addressed by mathematical modeling [30].
Previous attempts to model the Jak/Stat pathway have
either focused on steady state responses or on capturing the
transient activation proﬁle of the pathway to understand its
kinetics [31–35]. Examining the transient activation proﬁle
provides a larger dynamic range of signal activation, and is
therefore more amenable to experimental investigation.
Although several models have made predictions about the
role of different signaling processes in Stat activation, little
work has been done to systematically understand how
different signaling events contribute to pathway control,
and to experimentally validate model predictions. Further-
more, a lack of computationally feasible algorithms for
assessing the importance of pathway structure on signaling
behavior has prevented an examination of the signaling
consequences of all possible intrapathway interactions. To
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Jak/Stat3 pathway to computationally screen and classify
parameter interactions for their effects on the transient
activation proﬁle of Stat3. In performing this global
sensitivity analysis, we were able to predict and experimen-
tally verify novel pathway dynamics such as a receptor-
concentration–dependent switch in ligand sensitivity. More-
over, this approach allowed us to group pathway interactions
into stimulatory- and inhibitory-signaling modules. By focus-
ing our computational analysis on signaling kinetics, we were
able to examine the consequence of pathway structure on the
kinetics of ligand desensitization. These results led to
predictive control of ESC self-renewal by modulating the
frequency of ligand stimulation.
Results
Simulation of the LIF-Induced Signaling Cascade
LIF-induced activation of Jak/Stat3 pathway was modeled
using mass action kinetics for the network structure in Figure
1. The equations for this SBML-compatible [36] system are
included in Figure S1, and Table S1 describes the parameters
according to MIRIAM standards [37]. Trafﬁcking was assumed
to be similar for all surface receptors [38]. Flow cytometry
(see Figure S2) demonstrated that surface expression of LIFR
and GP130 is unaffected by LIF addition, and that there is a
basal level of receptor turnover, consistent with previous
ﬁndings [26]. Model dependency on starting conditions [39]
was determined (see Figure S3), and showed stability over a
large range of values.
Simulation results of transient pathway activation as a
function of increasing LIF concentration are presented in
Figure 2, with exogenous LIF concentration shown in the ﬁrst
panel. In agreement with previous reports [40], there was
little difference in Stat3 activation between 500 and 1,000 pM
LIF. At 500 pM LIF, LIFR and GP130 receptor complexes
formed stabilized dimers in less than ten minutes. Cytoplas-
mic levels of Stat3 decreased by 4-fold during the ﬁrst 15 min
of LIF addition as Stat3 became phosphorylated and localized
to the nucleus, consistent with its observed kinetics in other
cells [41]. Even at 10 pM of exogenous LIF, the steady state
levels of activated Stat3 were at 60% saturation, and
signiﬁcant changes in SOCS3 induction were observed.
Simulations predicted a rapid activation and nuclear local-
ization of Stat3 with a peak at 20–25 min, and a time to
equilibrium of 2 h. Next, we experimentally validated model
predictions.
Validation of Model Predicted Kinetics
Model consistency with experimental output was deter-
mined by quantitative image analysis of mouse ESCs [1].
Figure 3A demonstrates how automated ﬂuorescence micro-
scopy combined with single cell image analysis was used to
distinguish signaling in undifferentiated ESCs based on
expression of stem-cell–maker Octamer-4 binding protein
(Oct4). The velocity of receptor activation was determined by
assessing the phosphorylation level of Jak (Janus Kinase)
during transient LIF stimulation (Figure 3B), and nuclear
accumulation of Stat3 (Figure 3C). Excellent agreement was
observed between experimental results and model predic-
tions. Analysis of the kinetics of SOCS3 transcription (Figure
3D) and nuclear accumulation of Tyr705 phosphorylated
Stat3 (Figure 3E) further supported model predictions.
Experimental results validated model predictions, suggesting
that the model can be used to investigate the effects of
perturbations in signaling parameters on Stat3 signaling
kinetics.
Novel Effects of Receptor Trafficking on Pathway
Activation
To determine the effects of changes in model parameters
on Stat3 signaling, we simulated transient pathway behavior
over a 40-fold range of values for each parameter to generate
Stat3 activation surfaces (see Figure S4 for a complete list). By
examining the surfaces for local minima and maxima, which
represent non-monotonic effects on Stat3 activation, we
found that the only parameter that provided such a response
was the production rate of GP130 receptors (Figure 4A). The
model predicted a biphasic response; a small increase in
receptor expression resulted in an increase in Stat3 activa-
tion; while signiﬁcant receptor overexpression attenuated
activation. In silico analysis suggested that transient forma-
tion of LIFR and GP130 nonsignaling receptor heterodimers,
and sequestering of LIFR by GP130 in the overexpressing
cells, is responsible for the observed results, which is
consistent with previous reports [28]. Removal of this
ligand-independent interaction from the model eliminated
the biphasic response to GP130 expression. To validate this
prediction, we developed several ESC lines which overexpress
the GP130 receptor to varying degrees (Figure 4B and 4C). As
predicted by the model (Figure 4D), Stat3 activation
increased upon an incremental GP130 overexpression but
decreased at higher levels of receptor expression (Figure 4E).
To demonstrate that the overexpressed receptors were in fact
functional, we examined Stat3 activation in response to IL-6
plus sIL-6R, which signals exclusively through GP130 recep-
tors [25,26]. Cells expressing higher levels of GP130 exhibited
higher levels of Stat3 activation upon IL-6 stimulation (Figure
4F), conﬁrming that the overexpressed receptors were func-
tional. As expected from the correlation between Stat3
activation and cell fate processes, modest receptor over-
expression appeared to enhance self-renewal in the absence
of exogenous LIF, while greater levels of receptor expression
increased differentiation (Figure 4B and 4C). In addition to
demonstrating the predictive power of this model, these
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Author Summary
Directing stem cell fate requires knowledge of how intracellular
signaling pathways integrate environmental stimuli to make
decisions to stay as stem cells (self-renew) or to differentiate into
specific functional cell types. We developed and validated a
computational model of signal transducer and activator of tran-
scription-3 (Stat3) pathway kinetics, a signaling network involved in
mouse embryonic stem cell (ESC) self-renewal. Our analysis
demonstrates that stem cell fate control is regulated by a distributed
set of parameters that positively and negatively regulate Stat3
activation. We further demonstrate that we can take advantage of
differences in the timing of signaling pathway activation and
inhibition to design a strategy to deliver self-renewal stimuli to stem
cells in a more efficient manner. Ultimately, the use of stem cells in
biotechnological applications will require an in-depth understand-
ing of how cells integrate diverse environmental stimuli to make cell
fate decisions.
Signaling Kinetics Predicts Stem Cell Fate Controlresults provide a range of parameter variations over which
Stat3 activation is monotonic (see Figure S5). This allowed us
to deﬁne a range of parameter values over which we could
perform a global sensitivity analysis of parameter interac-
tions.
Global Sensitivity Analysis Determines Mechanisms of
Pathway Control
To determine how different parameters control signal
propagation, and thereby impact ESC self-renewal, we
performed a global sensitivity analysis (GSA) on Stat3
activation. Model parameters were varied by 5-fold, and the
change in the activation proﬁle of Stat3 was quantiﬁed using
metrics such as Euclidean distance (see Figure S6 for a
complete list of metrics used). Sensitivity analysis of
parameters in isolation (Figure 5A) showed that the pathway
is more sensitive to SOCS3 inhibition than SHP2 or PIAS3.
However, parameter interactions have an important role in
signal control and must be considered in this context. To do
this, a GSA on Stat3 activation was performed for all two-
parameter interactions. This approach can be used to cluster
different interactions according to their impact on pathway
output. Since rows corresponding to parameters group closer
together if they interact similarly with other parameters, this
approach allowed us to cluster groups of similarly interacting
parameters. This approach provides a visual representation
that is easy to interpret. The results of this analysis, presented
in a clustergram (Figure 5B), show that it is possible to
distinguish parameters that contribute to pathway activation
(hatched circle) or inhibition (yellow circle), as well as to
identify interesting pathway interactions. For example,
simultaneously changing the nuclear export rate of Stat3
(K16, all rate constants described in Table S1) and the rate of
docking of Stat3 on activated receptors (K7) will inﬂuence
Stat3 activation more signiﬁcantly than either of these
parameters in isolation or in combination with any other
parameters. Our sensitivity analysis demonstrates that nu-
clear phosphatase activity, inhibition of SOCS3, and Stat3
nuclear export most signiﬁcantly inﬂuence Stat3 activation.
These results were unaffected by how much parameters were
changed (see Figure S7), and could be averaged over different
fold-changes in parameter values (see Figure S8).
To experimentally validate the GSA results, chemical
inhibitors were used to speciﬁcally target different pathway
activation steps (reducing their corresponding rates by 5-
fold) and the resultant Stat3 activation proﬁles were
compared with model predictions. For validation, we chose
to target nuclear export of Stat3 (K17) and receptor
phosphorylation (K5) because of the availability of speciﬁc
chemical inhibitors and the ability to directly measure the
reduction in each rate constant. A CRM-1–dependent nuclear
export blocker, Leptomycin-B, was used to reduce phos-
phorylated-Stat3 nuclear export, and a Jak-speciﬁc inhibitor
was used to reduce receptor complex phosphorylation. Dose
responses of the inhibitors were produced to determine the
exact concentrations required to reduce the corresponding
rate constants by 5-fold (see Figure S9). As predicted by the
model (Figure 5C), experimental results (Figure 5D) show that
a 5-fold reduction in surface complex activation by addition
of Jak inhibitor will reduce levels of activated Stat3, while a 5-
fold reduction in nuclear export of phospho-Stat3 increases
levels of activated Stat3. If both inhibitors are used simulta-
Figure 1. Network Structure of the Jak/Stat3 Pathway Shows Scheme for LIF-induced Activation of Stat3
Closed arrows indicate biochemical reactions, open arrows show transport such as transport into nuclear compartment, and double arrows indicate
reversibility. All surface receptors and complexes are internalized similarly, internalized complexes are degraded, and new receptors are constitutively
produced. Color-coded dots next to kinetic parameters correspond to grouping of parameters from Figure 5 as explained in text.
doi:10.1371/journal.pcbi.0030130.g001
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Signaling Kinetics Predicts Stem Cell Fate Controlneously, the upstream effect (K5) will dominate the response.
We also veriﬁed two other sensitivity analysis results involving
SOCS3 transcription and receptor production (K22,K29) and
SOCS3 translation and receptor production (K25,K29).
Model-predicted trends (Figure 5E) were observed experi-
mentally (Figure 5F). In this case, reduction of receptor
production decreased the level of Stat3 activation, and
reduction of SOCS3 production led to loss of signal
attenuation. Knockdown of SOCS3 using siRNA [42] veriﬁed
that it is responsible for signal attenuation (see Figure S9).
Therefore, global sensitivity analysis was used to cluster cell-
signaling steps based on intrapathway interactions and
identiﬁed biologically relevant control nodes of Stat3
activation.
In Silico Investigation of Desensitization to Ligand
Stimulation
Desensitization, which is the inability to respond to ligand
restimulation [26], may signiﬁcantly limit cytokine-driven in
vitro stem cell propagation [43]. Possible mechanisms of
desensitization in the Jak/Stat3 pathway include receptor
downregulation, SHP2- or SOCS3-mediated signal attenu-
ation, and differential transport kinetics of STAT3, but the
relative importance of each interaction is unknown. As a ﬁrst
step to investigate this response, model-predicted trends of
desensitization (Figure 6A) were experimentally veriﬁed
(Figure 6B), and showed that a minimum time of about 3 h
is required after ligand stimulation for the cells to become
fully responsive to the readdition of LIF. GSA of two
successive Stat3 activation proﬁles was used to understand
what pathway components control desensitization. This
method distinguishes between desensitization and inhibition,
since both successive activation proﬁles will be changed by
inhibition, but only the reactivation proﬁle is inﬂuenced by
desensitization. The relative shift of the reactivation proﬁle
of Stat3 (Figure 6C), and the sensitivity analysis (Figure 6D),
both showed that the decreased production of SOCS3 and a
reduction of Stat3 nuclear export (together or independ-
ently) could delay the Stat3 reactivation proﬁle. The main
determinants of desensitization control, in order of impor-
tance, were SOCS3, nuclear phosphatase, and nuclear export
of Stat3. Our analysis also suggested that receptor turnover
rates inﬂuence desensitization.
To determine if Jak/Stat3 pathway desensitization control
could impact ESC self-renewal, we experimentally modulated
the frequency of LIF-mediated Stat3 stimulation based on the
period of cytokine supplementation. Dose responses of Stat3
activation and Oct4 expression at different LIF concentra-
tions identiﬁed 10 pM LIF as the minimum concentration
that maintains undifferentiated (Oct4þ) ESC cells and does
not saturate Stat3 activation (Figure 6E and 6F). We reasoned
that small modulations of Stat3 above and below this level
would reveal sensitivities to desensitization, and thus this
concentration of LIF was cycled at two different periods to
investigate the impact of desensitization on self-renewal of
ESCs. According to our predictions, a 6-h LIF-supplementa-
tion period would provide sufﬁcient time (3 h) for Stat3
signaling to reach a minimum and for cells to lose their
‘‘memory’’ of previous LIF levels (Figure 6G). In contrast, a 1-
h LIF-supplementation period would result in an increased
minimum level of activated Stat3 (Figure 6E–6G) due to
desensitization-mediated effects. Consequently, the 1-h LIF
Figure 2. Computational Simulation of Jak/Stat3 Pathway Activation at Different LIF Concentrations Shows Transient Kinetics
LIF was added in increasing concentrations of 10, 50, 500, and 1,000 pM in the direction of arrow. LIFRC is the complex of LIFR with LIF, LIFRGP130CP is
the phosphorylated heterodimeric complex of LIFR and GP130, STAT3DPN is nuclear Tyr705 phosphorylated Stat3, STAT3DN is nuclear Stat3,
SOCS3MRNAN and SOCS3MRNA are the nuclear and cytoplasmic levels of SOCS3 mRNA, and BOUND-SOCS3 is the total number of receptor complexes
which are bound to SOCS3. This representative simulation was run for 200 min, and the number of activated proteins per cell are plotted as a function
of time.
doi:10.1371/journal.pcbi.0030130.g002
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Signaling Kinetics Predicts Stem Cell Fate ControlFigure 3. Experimental Validation of Model Output
(A) Representative images of mouse ECS for quantitative single cell fluorescence microscopy. Hoechst nuclear stain is used to determine location of
nuclei, a nuclear mask is drawn, and average fluorescence levels in the mask are used to determined levels of phosphorylated Stat3 and Oct4.
(B–D) Show agreement between model-predicted trends and experimental results of activation profiles of Jak phosphorylation, nuclear retention of
Stat3, and SOCS3 induction, respectively. For Jak phosphorylation, nuclear accumulation of Stat3, and SOCS3 induction, both experimental and
simulation results were normalized based on the maximum of the activation profiles for each of these proteins. For nuclear accumulation of
phosphorylated Stat3 the results were normalized based on a steady state level in 500 pM LIF.
(E) The model-predicted activation profile of nuclear retention of Tyr-705 phosphorylated Stat3 is shown in solid line and is in agreement with
experimental data points.
doi:10.1371/journal.pcbi.0030130.g003
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Signaling Kinetics Predicts Stem Cell Fate Controlcycle should maintain a higher percentage of Oct4þ cells. To
experimentally test this prediction, periodic LIF supplemen-
tations were performed for a total of 72 h, and the impact of
these manipulations on Oct4 expression in ESCs was
determined. Results indicated that although total exposure
to LIF was the same between these two conditions, the
percentage of Oct4þ cells was higher in the 1-h periodic LIF
stimulation condition (Figure 6H and 6I). Therefore, the
desensitization period may provide windows of opportunity
for ESCs to lose memory of previous ligand concentrations
and differentiate. Desensitization of the Jak/Stat3 pathway
provides an example of how pathways kinetics inﬂuences ESC
fate choices.
Discussion
The Jak/Stat3 pathway, which is required for self-renewal of
mouse ESCs, was modeled using a deterministic, lumped-
Figure 4. GP130 Overexpressing Cell Lines Show Non-Monotonic Response of Stat3 Activation to Receptor Overexpression
(A) The model-predicted surface of Stat3 activation is shown as a function of time and change in production of GP130 receptors. Successive increase in
GP130 production as shown by black, green, and red arrows in that order shows a non-monotonic response of Stat3 activation and the presence of a
local maximum. This is illustrated by the circle in the contour map on the x–y plane.
(B) GP130 overexpressing cell lines RG1–RG5 were developed to express the receptor at varying levels compared with R1 cells, and these cell lines retain
Oct4 expression in the presence of LIF (C).
(D) Model-predicted trends of GP130 overexpression corresponding to (A) shows normal profile of Stat3 activation (black line), Stat3 activation in slight
GP130 overexpression (green line), and significant GP130 overexpression (red line).
(E) Experimental results show a consistent trend in LIF-induced Stat3 activation profile using RG1 and RG5 cell lines in comparison with model resultsi n
(D).
(F) IL-6 stimulation of GP130 overexpressing cell lines shows a dose-dependent increase in Stat3 activation as a function of GP130 overexpression.
doi:10.1371/journal.pcbi.0030130.g004
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Signaling Kinetics Predicts Stem Cell Fate Controlparameter, differential-equation–based representation of
mass action kinetics. Model-predicted trends of Stat3
activation and nuclear accumulation as well as Jak activation
and SOCS3 expression were veriﬁed experimentally by
quantitative imaging of adherent mouse ESCs. These results
provided evidence for biological relevance of model pre-
dictions, and led to further investigation of pathway control.
Transient Stat3 activation was used to understand how
different signaling events inﬂuence pathway kinetics, and
grouping of model parameter interactions determined the
important intracellular signaling control modules. Sensitivity
analysis of model parameters in isolation predicted that
signiﬁcant GP130 overexpression should reduce Stat3 activa-
tion. Experimental results of GP130 overexpressing cell lines
conﬁrmed predictions, showing decreased Stat3 activation
with increased expression of GP130 receptors. Intact bio-
logical function of overexpressed receptors was conﬁrmed by
IL-6 stimulation of the cells. Based on model results,
sequestering of LIFR by GP130 to form a nonsignaling
heterodimer, which has been shown to exist transiently [12],
can account for this behavior. Higher differentiation was
observed in the highest GP130 overexpressing cell lines in the
absence of LIF (Figure 4C). This response may be attributed
either to reduced Stat3 activation from endogenously
produced GP130 ligands [44] or possibly to increased
activation of ERK by SHP2 through the GP130 receptors
contributing to the response [25,45].
Global sensitivity analysis of the system was performed by
considering two parameter interactions; this approach
covered the entire solution space of these interactions and
provided a computationally feasible method to perform this
analysis compared with previous attempts [31]. Clustering
(Figure 5B) demonstrated how different parameters interact
to yield similar effects. It is noteworthy that sets of inhibitory
and stimulatory signaling interactions appeared distributed
across the signaling network. Points of sensitivity may
represent important nodes of crosstalk between pathways,
and nonintuitive pathway behavior could arise from the
alteration of seemingly innocuous parameters. These possi-
bilities may in part account for the observation that
conserved signaling pathways affect a variety of cell processes
in a cell-type and context-dependent manner. A number of
other signaling pathways have recently been implicated in
ESC self-renewal; this analysis provides a ﬁrst step toward
understanding this signaling crosstalk.
GSA results were veriﬁed experimentally by speciﬁcally
targeting signaling steps for which speciﬁc inhibitors were
available. The impact of a reduction in the rates of nuclear
export of Stat3- and Jak-mediated receptor activation in
isolation and in combination were determined experimen-
tally and corroborated model predictions. Interaction of two
targets, which clustered together in the GSA, SOCS3
induction and receptor production, was veriﬁed, demonstrat-
ing that they synergize similarly. Although this sensitivity
Figure 5. Global Sensitivity Analysis Based on Stat3 Activation
(A) Individual rate constants were changed 5-fold, and a Euclidean distance measurement was used to determine the resultant change in the Stat3
activation profile. Normalized Euclidean distance measurements are plotted to show the sensitivity of Stat3 activation to each parameter.
(B) Global sensitivity analysis results show changes in Stat3 activation (measured by Euclidean distance) due to 5-fold changes in combinations of
parameters pairs, shown along the x- and y-axis. The sensitivity is represented using color code, with corresponding Euclidean distance values shown in
the color bar. Hierarchical clustering (indicated on the left) is based on correlations between rows of rate constants to demonstrate groups of
parameters which interact similarly. Clustering was perfomed using Matlab software by Mathworks. Rate constants, which are grouped together, are
color-coded using circular dots, and the color code is included in Figure 1. Sensitivity analysis predictions for the Stat3 nuclear export parameter
(marked by square), and receptor phosphorylation (marked by triangle), and their interaction (marked by circle) are shown in (C). Sensitivity trends
which were predicted in (C) are experimentally verified (D), demonstrating that predicted trends are relevant.
(E) Sensitivity analysis trends of interaction of SOCS3 transcription and receptor production (marked by hexagon) and SOCS3 translation and receptor
production (marked by cross) are in agreement with experimental results shown in (F).
doi:10.1371/journal.pcbi.0030130.g005
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Signaling Kinetics Predicts Stem Cell Fate Controlanalysis focused on Stat3 activation due to its importance to
self-renewal of mouse ESCs; the same analysis could be
performed for any protein in the signal transduction pathway
(see Figure S10). Based on GSA, nuclear export of Stat3,
nuclear phosphatase activity, and inhibition by SOCS3 were
the most sensitive parameters for manipulating pathway
output. Although other mechanisms of desensitization, in
particular receptor desensitization or differential transport
kinetics between phosphorylated and unphosphorylated
receptors, are possible, our investigation points out a series
of possible mechanisms through which desensitization can
occur. More importantly, this approach allows for determi-
nation of importance of each mechanism to desensitization.
Computational investigation of the dynamics of pathway
desensitization to ligand stimulation was a particularly
interesting application of GSA. In agreement with previous
reports, SOCS3, but neither SHP2 nor PIAS3 kinetics, could
account for pathway desensitization [26].
Figure 6. Desensitization of ESCs to LIF Stimulation Can Be Investigated Computationally and Used to Control Self-Renewal
(A) Model-predicted trends of desensitization of Stat3 activation to LIF stimulation. Color bar inset shows history of 500 pM LIF stimulations.
(B) Experimental results are in agreement with model-predicted desensitization kinetics in (A) and show a gradual loss of desensitization in absenceo f
ligand.
(C) Global sensitivity analysis shows parameter interactions which result in right-shift (positive minutes) or left-shift (negative minutes) in restimulation
profile of Stat3. Shift in the profile was determined from the maximum of cross-correlation of two consecutive Stat3 activation profiles.
(D) Sensitivity analysis clustergram shows Euclidean distance measurement between two consecutive Stat3 activation profiles and distinguishes
parameter interactions which influence desensitization by changing the restimulation profile.
(E) Experimental results of dose response of Stat3 activation to LIF show the steady state response as well as the peak values of Stat3 activation during
transient LIF stimulation.
(F) Dose response of Oct4 expression after 72 h at different LIF concentrations.
(G) Stat3 activation profiles for 10 pM LIF stimulation with 1-h and 6-h periods in red and blue, respectively. During 6-h cycles, LIF is removed for 3 h
during which time a lower Stat3 activation level is observed in comparison with the 1-h period.
(H) Histograms of Oct4 expression show that 1-hr period of LIF stimulation (red) maintains a higher percentage of Oct4þ cells than 6-h period of LIF
stimulation after 72 h.
(I) Oct4 expression of cells maintained for 72 h in different conditions shows that the percentage of Oct4þcells in the 1-h period is higher than the 6-h
period and comparable to 500 pM constant LIF levels.
doi:10.1371/journal.pcbi.0030130.g006
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Signaling Kinetics Predicts Stem Cell Fate ControlThe phenomena of desensitization is an interesting feature
of the Jak-Stat signaling pathway, which lends itself to a
computational approach for identifying methods of circum-
venting this inhibitory behavior. To do this, we predicted the
effects of two different ligand-dosing frequencies on Stat3
activation and examined their consequences on ESC fate.
Although both sets of conditions were exposed to the same
overall amount of LIF, the conditions with the LIF cycle
period of 1 h retained a higher percentage of Oct4þ cells.
Therefore, knowledge of dynamic pathway behavior such as
desensitization can be used to identify nonintuitive targets or
cell culture manipulations to control stem cell behavior.
In summary, directing stem cell fate requires knowledge of
how intracellular signaling can be controlled. To do this, we
used a combined computational and experimental approach
to study the kinetics of the Jak/Stat3 pathway in mouse ESCs.
Although such mass action kinetics models can be improved,
for example by including more detailed reaction mechanisms
and interpathway interactions, this approach utilized herein
provided us with an appropriate representation of the
network dynamics and has allowed identiﬁcation of interest-
ing behaviors and properties of this signaling pathway.
Modeling predicted novel effects of signaling (which were
experimentally veriﬁed), and global sensitivity analysis led us
to understand how this pathway is controlled. Based on
computational predictions of desensitization kinetics, the
self-renewal response of ESCs was modulated by controlling
the frequency of ligand stimulation. This approach is useful
for optimizing stem cell cultures by providing a ligand
delivery regimen based on knowledge of intracellular signal-
ing pathway kinetics. Our approach can be used to ﬁnd key
targets for control of intrapathway kinetics in stem cells.
What is now required is to develop direct links between the
nuclear concentration of activated Stat3 and cell fate
decisions in individual cells. Ultimately, this requires insight
into how cells convert graded stimuli into a threshold-based
cell fate decision. Adapting the model presented herein to
single cell signaling and integrating it with approaches to
describe gene regulatory networks will yield a deep under-
standing of stem cell self-renewal.
Materials and Methods
Model development and implementation. The Matlab software
package (The Mathworks, http://mathworks.com) was used for model
development and implementation. Signal propagation starts with
binding of LIF to its LIFR [10,11]; this is followed by recruitment of
the glycoprotein 130 (GP130) receptor to form a stabilized hetero-
dimeric receptor complex on the cell surface. Transient homodimers
of LIFR and GP130 are nonsignaling in this system [12]. LIF-mediated
heterodimeric receptor complex formation leads to activation of
receptor-associated Jaks, which phosphorylate the complementary
SH2 domain of both LIFR and GP130 [24,25]. The transcription
factor Stat3 then docks on the phosphorylated SH2 domains of the
receptor heterodimer and is phosphorylated at Tyr705 by Jak [23]. In
this model, we assumed pre-association of Jak with the receptors
according to literature [21,22], and we have assumed reversible
kinetics as shown by double arrows in Figure 1 [20]. Stat3 is
predominantly dimeric [17–19] and cytoplasmic [15,17] in its
unphosphorylated form, and translocates to the nucleus upon
phosphorylation by using the importin machinery, in particular
importin a3–5 [15,24]. In addition to ligand-mediated nuclear import
of Stat3 [15,16], there is a basal level of nuclear–cytoplasmic shuttling
of unphosphorylated Stat3 [15,17], and dephosphorylation of
phosphorylated nuclear Stat3 leads to its CRM-1 dependent nuclear
export [14]. We modeled these events by reversible binding of Stat3 to
activated receptor complexes (rate constants K7, K8), nonreversible
phosphorylation and dissociation of Stat3 from the receptor complex
[13] (K9), followed by reversible nuclear translocation of both
phosphorylated and unphosphorylated Stat3. We used a set of
lumped parameters for all nuclear transport events (K13–17) where
import rates are similar [34,38]; however, the export rate of
phosphorylated Stat3 is lower, in accordance with previous work
[14,41]. We optimized this proﬁle by tuning the export rate constant
of phosphorylated Stat3 based on the rise time of its activation
proﬁle as determined experimentally. Three important inhibitors of
the Jak/Stat3 pathway are also implemented. SOCS3 is under
transcription control of Stat3 [26,27], binds to the activated receptor
complex of LIF and GP130 by binding to the Tyr974 of the GP130
receptor in the complex, and renders it inactive by removing the
ability of Jak to phosphorylate Stat3 [25,26]. Transcription control of
SOCS3 by Stat3 and transport rates for the mRNA were modeled by
using lumped parameters. Translated SOCS3 protein binds reversibly
to the activated herterodimeric receptor complex and renders it
inactive, and it dephosphorylates the receptor complex while
remaining bound. The second inhibitor of the pathway, PIAS3, has
been shown to be present in both nuclear and cytoplasmic compart-
ments, to bind directly to phosphorylated Stat3, is believed not to be
under the transcription control of Stat3, and removes the DNA
binding ability of phospho-Stat3 [26]. We modeled PIAS3 activity by
two reversible binding steps in the cytoplasm and nucleus. Finally, the
effect of SHP2, which is the third main inhibitor of the pathway, was
captured in the dephosphorylation of the Src-Homology-2 SH-2
domain phosphorylated receptor heterodimer complexes, using rate
constant (K6). This is the suggested mode of action of SHP2 in this
system [21,24–26]. Trafﬁcking of the receptors GP130 and LIFR is also
implemented in the model, and all surface receptors can be
internalized with the same rate constant (K28), there is a ﬁxed rate
of receptor production using rate constant K29, and internalized
complexes do not signal and are degraded [11,28,29]. Using this
system, we are able to capture the observed transient kinetics of the
Jak/Stat3 pathway.
ESC culture. Undifferentiated R1 were maintained in a mixture of
15% fetal bovine serum (FBS) (900–108; Gemini Bio-Products, http://
www.gembio.com/), 100 lM b-mercaptoethanol (M6250; Sigma-
Aldrich, http://sigmaaldrich.com), 2 mM L-glutamine (25030–081;
Invitrogen, http://www.invitrogen.com), 0.1 mM nonessential amino
acids (11140–050; Invitrogen), 1 mM sodium pyruvate (11360–070;
Invitrogen), 50 U/mL penicillin and 50 lg/mL streptomycin (15140–
122; Invitrogen) in high-glucose Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) supplemented with 500 pM murine leukemia inhibitory
factor (mLIF; ESG11–7; Chemicon, http://www.chemicon.com), on
0.2% gelatin-coated tissue-culture ﬂasks. Single-cell suspensions were
obtained by incubating the cells with 0.25% Trypsin-EDTA (25200–
106; Gibco, http://www.invitrogen.com) for 3 min, and 1 3 10
6 cells
were plated in a T25 between subsequent passages, using only cells
from passages 15 to 30.
Transient LIF stimulation assays. In order to obtain adherent cells,
special optic ﬂat-bottom, clear 96-well plates (3614; Corning, http://
www.corning.com) were precoated with 1% Fibronectin (F1141;
Sigma-Aldrich) in 0.02 % Gelatin at 37 8C and 5% CO2 for 24 h.
Single-cell suspension of R1 ESCs was obtained as outlined above.
Cells were plated in 200 ul per well of ESC culture media at a density
of 1.5 3 10
4 cells per well of a 96-well plate, spun using appropriate
plate holders at 220 G for 5 min, and incubated at 37 8C and 5% CO2
for 4 h in order to allow cell attachment. Thereafter, media was
changed to ESC culture media without LIF and with FBS replaced
with 15% knockout serum replacement (KO media) (10828–028;
Invitrogen), and cells were incubated in this media at 37 8C and 5%
CO2 for 24 h before LIF stimulation. LIF stimulation was performed
by adding KO media containing 500 pM LIF at predeﬁned time
points and ﬁxing the cells at time zero with 3.7% formaldehyde in
phosphate-buffered saline (PBS). For inhibitor studies, the inhibitors
were added at the appropriate concentration in KO media at 200 ul/
well for 4 h before LIF stimulation. Jak Inhibitor-1(420099;
Calbiochem, http://www.merckbiosciences.co.uk) was used at concen-
tration 5 nM as determined by dose response curves and Leptomycin-
B (L2913, Sigma Aldrich) was used at concentration 10 ng/ml (see
Figure S9 for dose responses), with appropriate controls containing
equal concentration dimethyl sulfoxide (DMSO) (D2650; Sigma-
Aldrich).
High-content single-cell ﬂuorescence microscopy of adherent
ESCs. For intracellular staining, the cells are permeablized with 100
ll per well methanol for 3 min at room temperature and washed
three times with 200 ll per well of PBS. To reduce nonspeciﬁc
binding of antibody, 200 ul of 10% FBS in PBS is added to each well,
and the plate was kept at 4 8C for 24 h. Antibody dilutions were
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primary antibodies were used with 24-h incubation: anti-phospho-
Stat3 (tyr705) (9131; Cell Signaling Technology, http://www.cellsignal.
com/), anti-Oct3 (Oct4) (611203; BD Bioscience, http://www.
bdbiosciences.com/), anti-phospho-Jak2 (Tyr1007–1008) (3771; Cell
Signaling technology), anti-LIFR (Sc659-Santa Cruz Biotechnology,
http://www.scbt.com/), anti- GP130 (Sc656-Santa Cruz Biotechnology),
and anti-SOCS3 (Sc9023-Santa Cruz Biotechnology). The following
secondary antibodies were used with 2-h incubation: AlexaFluor 488
(A-11034), and AlexaFluor 546 (A-11030; Molecular Probes, http://
www.probes.invitrogen.com). Hoechst nuclear dye (B2261; Sigma-
Aldrich) was used at 0.1 ug/mL.
Cells were scanned using the ArrayScan VTI automated ﬂuorescent
microscope (Cellomics, http://www.cellomics.com/). Image analysis was
performed using the vHSC View software provided by Cellomics.
Object selection was performed based on Hoechst staining of nuclei,
and images of appropriate channels (for example, Oct4 and Phospho-
Stat3) were analyzed to determine the average pixel intensity for each
cell. Oct4 subpopulations were determined by ﬁtting two Gaussian
distributions (OriginPro 7.5; OriginLab, http://www.originlab.com/) to
log-transformed data of Oct4 ﬂuorescence. All experiments were
performed at least in triplicate, and at least 30,000 cells were imaged
per data point.
Flow cytometry and receptor expression assays. Cells were ﬁxed
after LIF addition at appropriate time points (see Figure S2) using
Reagent 1 containing 5.5% formaldehyde (IM2389, Immunotech,
http://www.beckmancoulter.com) in 2% FBS Hank’s Buffered Salt
Solution (HBSS) (14175–095-Gibco) for 15 min. Permeablization (in
the case of permeablized cells) was done in Reagent 2 containing
0.1% sodium azide (IM2389, Immunotech) for 5 min, followed by
incubation with the appropriate primary antibody for another 15
min. Primary antibodies that were used are listed above, and the
secondary antibodies that were used are PE anti-mouse IgG1 (550083;
BD Bioscience) and Goat-anti-rabbit FITC (0833; Immunotech).
Development of GP130 overexpressing cell lines. GP130 cDNA was
provided by Kishimoto et. al [41]. The PCR-ampliﬁed fragment was
subsequently inserted into the pCAG-GFP vector provided by Dr. J.
Draper [46] using the Xho1 and Not1 sites. The cloned product was
sequenced. R1 ESCs were transfected by electroporation, and stable
transfectants were selected using Puromycin resistance. Five cell lines
(RG1–RG5) were expanded and cell-surface GP130 overexpression
was conﬁrmed by both ﬂow cytometry and Cellomics imaging.
SOCS3 siRNA construction and transfection. siRNA transfections
were performed using Lipofectamine transfection reagent (18342–
012; Invitrogen). siRNA for murine SOCS3 (sense, 59-GGAG-
CAAAAGGGUCAGAGGtt-39; antisense, 59-CCUCUGACCCUUUUG-
CUCCtt-39) [42] was custom-manufactured (16211; Ambion, http://
www.ambion.com). Transfection was performed on adherent cells in
KO media without antibiotics, in a volume of 200 ul/well containing
160 ul of plating media, 1–50 pMol of siRNA, and 0.3–0.8 ul of
Lipfectamine reagent. After dose response, the optimum condition
was found to be 11.4 pmol of siRNA in 200 ll of plating media
containing 0.4 ll of Lipfectamine, which was made according to
manufacturer instructions (18342–012; Invitrogen). Cells were plated
in the transfection reagent 24 h before readout.
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